Clinical Trials Logo

Filter by:
NCT ID: NCT02818608 Completed - Stroke Clinical Trials

Transcranial Direct Current Stimulation and Functional Electrical Stimulation for Upper-limb Rehabilitation After Stroke

Start date: August 14, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to verify the effectiveness of tDCS combined with FES on upper limb rehabilitation of post-stroke subjects with moderate and severe compromise.

NCT ID: NCT02817867 Completed - Stroke Clinical Trials

Association Between Brain Stimulations for the Rehabilitation of Chronic Stroke Patients

Start date: June 2016
Phase: N/A
Study type: Interventional

Cerebrovascular accident (CVA) is a cerebrovascular disease with high incidence and morbidity in the Brazilian population, and is considered a major cause of disability in adults. Brain damage caused by stroke generates a maladaptive pattern of neural activity and modulation between the cerebral hemispheres, unbalancing in the inter-hemispheric inhibition. This condition affects patient's functional recovery. The aim of this study is to verify the effectiveness of repetitive transcranial magnetic stimulation Association (rTMS) in the cortex motor contralesional, Transcranial Direct Current Stimulation (tDCS) in the motor cortex ipsilesional and the association between these two types of brain stimulations on the upper limb recovery after stroke.

NCT ID: NCT02817750 Completed - Healthy Clinical Trials

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Start date: July 5, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics of the new formulation of zolpidem hemitartarate orodispersible tablet 3.5 mg in male and female healthy volunteers.

NCT ID: NCT02817139 Recruiting - Migraine Disorders Clinical Trials

Transcranial Direct Current Simulation in Chronic Migraine

Start date: June 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study is a pilot, double-blind, placebo-controlled, randomized trial aiming to compare the effects of transcranial direct current stimulation in Chronic Migraine.

NCT ID: NCT02816593 Completed - Discolored Teeth Clinical Trials

In-office and At-home Tooth Bleaching Using Low Concentration Peroxides.

Start date: August 2015
Phase: N/A
Study type: Interventional

To evaluate the efficacy, safety and impact on quality of life related to oral health of home and office tooth whitening techniques in young individuals.

NCT ID: NCT02816541 Completed - Motor Disorders Clinical Trials

Effects of Pilates-based Therapeutic Exercises on the Postural Control

Start date: July 2016
Phase: N/A
Study type: Interventional

The Pilates Method (PM) has been widely used in the daily practice of many professionals. It is well known that anticipatory postural adjustments (APAs) have a strong relation with the improvement in performance through motor control improvement. However, no studies have investigate the PM exercises performed with pelvis in different positions on the improvement of performance, APAs and these influences on motor control. This study aims to compare the effects of practicing a single session of Pilates-based therapeutic exercises with posterior pelvic tilt and neutral position of the pelvis on the APAs of elderly subjects.

NCT ID: NCT02815826 Completed - Barefoot Running Clinical Trials

16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners

Start date: September 2012
Phase: N/A
Study type: Observational

The purpose of this study was to evaluate the influence of 16 weeks of progressive barefoot running training on impact force and muscle activation in habitual shod runners. Habitual shod runners were tested barefoot (BF) and shod (SH), before and after 16 weeks of progressive barefoot running training. Tests consisted of running on instrumented treadmill at 9 km/h, for 10 minutes in each experimental condition. Nine data acquisitions (10 s) of vertical ground reaction force (VGRF) and electromyographic (EMG) signal were conducted in each experimental condition, for each test.

NCT ID: NCT02815358 Completed - Lumbar Pain Clinical Trials

Effects of Segmental Stabilization on the Anticipatory Postural Adjustment of Subjects With Lumbar Pain

Start date: June 2016
Phase: N/A
Study type: Interventional

This study aims to verify the effects of a segmental stabilization exercise program on the anticipatory postural adjustment of subjects with chronic lumbar pain. The effects will be assessed by means of superficial electromyography focused on the registry of the onset of multifidius and deltoid (anterior and posterior) activity during a repetitive shoulder flexion/extension.

NCT ID: NCT02814175 Completed - Psoriatic Arthritis Clinical Trials

A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

CONTROL
Start date: August 5, 2016
Phase: Phase 4
Study type: Interventional

An interventional Phase 4 open-label, randomized, controlled, parallel-group, multi-country study in participants with psoriatic arthritis (PsA) consisting of 2 parts: Part 1 (Day 1 up to Week 16) is designed to compare the achievement of minimal disease activity (MDA) between participants randomized to either adalimumab in combination with methotrexate (MTX) or MTX alone escalated to the highest recommended or tolerable dose; Part 2 (Week 16 through Week 32) is designed to evaluate the maintenance or achievement of MDA on 4 different treatment regimens using adalimumab and/or MTX, with participant allocation based on the initial randomized treatment and achievement of MDA in Part 1, and with rescue treatment option.

NCT ID: NCT02814058 Completed - Healthy Clinical Trials

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

Start date: July 5, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics of the new formulation of zolpidem hemitartarate orodispersible tablet 1.75 mg in male and female healthy volunteers.